Published in TB and Outbreaks Week, January 15th, 2002
Qualified microbiologists, currently working on anthrax testing at a university laboratory, finished first tests with BioShield's new formulation proving the efficacy against B. anthracis spores and the bacteria that causes anthrax. The information has been compiled and submitted to the U.S. Environmental Protection Agency (EPA) for review and consideration. If accepted, BioShield Technologies (BSTI) will be able to offer this product to the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.